Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.33
-0.2800-0.61%
Post-market: 45.330.00000.00%19:59 EDT
Volume:7.61M
Turnover:344.95M
Market Cap:200.50B
PE:11.32
High:45.61
Open:45.28
Low:44.95
Close:45.61
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.68
T/O Rate:0.24%
Dividend:1.72
Dividend Rate:3.80%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.16
PE(LYR):12.52

Loading ...

Novo Nordisk Reportedly Seeks Lower Prices From Suppliers to Stay Competitive

MT Newswires Live
·
Jul 02

Why Medicare Isn't a Game Changer for Weight-loss Drugmakers

Dow Jones
·
Jul 02

Moderately bullish activity in Novo Nordisk with shares up 1.51%

TIPRANKS
·
Jul 02

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 02

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading

MT Newswires Live
·
Jul 01

Movement Alert|Novo Nordisk Rises 3.18% in Regular Trading, US Medicare Begins Covering GLP-1 Weight-Loss Drugs for First Time

Market Focus
·
Jul 01

The Latest Senior-citizen Special is Here: Cheap Weight-loss Drugs

Dow Jones
·
Jul 01

Novo Holdings CEO Says Commitment to Planetary Health Investing Remains Steadfast

Reuters
·
Jul 01

Medicare GLP-1 Bridge Program Will Pay for Novo, Lilly Drugs

Dow Jones
·
Jul 01

Millions of Americans Can Get Medicare to Cover Glp-1s for Weight Loss Starting This Week. Here's How Much it Costs.

Dow Jones
·
Jul 01

US Medicare to Cover Weight-Loss Drugs for the First Time from July, Boosting Novo Nordisk Shares

Deep News
·
Jun 30

Jefferies Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Jun 30

Canada Approves Apotex's Bid to Sell Generic Version of Wegovy

Dow Jones
·
Jun 30

Novo Nordisk Accelerates Share Buybacks Under DKK 15 Billion Programme

TIPRANKS
·
Jun 30

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 30

FDA Set to Review Sandoz's Generic Glp-1s

Reuters
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Sanofi (SNY)

TIPRANKS
·
Jun 29

Older Americans Will Soon Have Medicare Access to Glp-1s for Weight Loss for the First Time. Here's What They Need to Know.

Dow Jones
·
Jun 28

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
Jun 27

Novo Nordisk Tests Cagrilintide in Patients Who Cannot Tolerate GLP-1 Weight-Loss Drugs

TIPRANKS
·
Jun 26